Shattuck Labs, Inc. (STTK) Stock Grade

About Shattuck Labs, Inc.'s fundamentals

Shattuck Labs is a biotechnology company with a market capitalization of $581.1 million that reported a significant net loss in its latest annual statement, reflected in a net margin of -4880.9%. The company experienced severe revenue contraction, with year-over-year revenue declining 82.5%, indicating a dramatic pullback in commercial activity or product sales. The company does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not meaningful given the unprofitable operations.